References
- Vítek L, Jirsa M, Brodanová M, Kalab M, Marecek Z, Danzig V, Novotný L, Kotal P. Gilbert syndrome and ischemic heart disease: A protective effect of elevated bilirubin levels. Atherosclerosis 2002;160:449–456.
- Horsfall LJ, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, Petersen I. Serum bilirubin and risk of respiratory disease and death. JAMA 2011;305:691–697.
- Johnson L, Bhutani VK. The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Perinatol 2011;35:101–113.
- Aspberg S, Dahlquist G, Kahan T, Källén B. Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma. Pediatr Allergy Immunol 2010;21:e733–e739.
- Dahlquist GG, Patterson C, Soltesz G. Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 1999;22:1698–1702.
- Raimondi F, Indrio F, Crivaro V, Araimo G, Capasso L, Paludetto R. Neonatal hyperbilirubinemia increases intestinal protein permeability and the prevalence of cow’s milk protein intolerance. Acta Paediatr 2008;97:751–753.
- Raimondi F, Crivaro V, Capasso L, Maiuri L, Santoro P, Tucci M, Barone MV, et al. Unconjugated bilirubin modulates the intestinal epithelial barrier function in a human-derived in vitro model. Pediatr Res 2006;60:30–33.
- Indrio F, Raimondi F, Laforgia N, Riezzo G, Polimeno L, Francavilla R. Effect of hyperbilirubinemia on intestinal permeability in healthy term newborns. Acta Paediatr 2007;96:73–75.
- American Academy of Pediatrics Subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
- Dani C, Poggi C, Barp J, Romagnoli C, Buonocore G. Current Italian practices regarding the management of hyperbilirubinaemia in preterm infants. Acta Paediatr 2011;100:666–669.